You are here

obesity

Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1

BioSpace

Wed, 11/13/24 - 11:20 am

Hidden data on obesity prospect wipe $12B off Amgen market cap

Fierce Biotech

Wed, 11/13/24 - 11:10 am

clinical trials

Radella reports positive outcomes from trial of MD-18 for obesity and diabetes

Clinical Trials Arena

Fri, 11/8/24 - 11:34 am

Radella Pharmaceuticals

clinical trials

Viking data provide latest test of oral obesity drug potential

BioPharma Dive

Mon, 11/4/24 - 06:54 pm

Viking Therapeutics

clinical trials

AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial

MSN/Reuters

Mon, 11/4/24 - 11:25 am

clinical trials

Endeveco Bio spin-off to launch obesity trial

Clinical Trials Arena

Mon, 11/4/24 - 11:07 am

Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data

Investors Business Daily

Sun, 11/3/24 - 10:10 pm

Viking Therapeutics

clinical trials

Boehringer Ingelheim drops obesity drug from Gubra partnership

Fierce Biotech

Thu, 10/31/24 - 10:45 pm

Boehringer Ingelheim

Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year

BioSpace

Thu, 10/31/24 - 09:42 am

Novo takes big step toward ending Ozempic, Wegovy shortages

BioPharma Dive

Wed, 10/30/24 - 08:48 pm

Lilly shares fall as obesity drug sales miss forecasts

BioPharma Dive

Wed, 10/30/24 - 11:52 am

Weight-loss drugs didn't curb health costs within two years

Reuters

Thu, 10/24/24 - 11:11 am

Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market

Reuters

Thu, 10/24/24 - 09:53 am

1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move

Motley Fool

Thu, 10/17/24 - 09:24 am

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Medicare coverage of weight loss drugs would cost $35B: CBO

The Hill

Wed, 10/9/24 - 08:56 pm

Weight loss gold rush: Developers vie for next blockbuster treatment

Pharmaphorum

Tue, 10/8/24 - 09:45 am

Boehringer Ingelheim

Scholar Rock scores with ‘surprise’ success in SMA drug study

BioPharma Dive

Mon, 10/7/24 - 11:52 am

spinal muscular atrophy

Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings

Forbes

Wed, 10/2/24 - 11:20 am

Kailera launches with $400M series A and clutch of Chinese obesity drugs

Fierce Biotech

Tue, 10/1/24 - 09:57 am

Kailera Therapuetics

Cerevel Therapeutics

Pages